Navigation Links
Atherosclerosis: Specific microRNAs promote inflammation
Date:3/22/2013

Atherosclerosis, an inflammatory reaction, is at the root of the most common forms of cardiovascular disease. Researchers at Ludwig-Maximilians-Universitaet (LMU) in Munich have now identified a microRNA that plays a prominent role in the process, and offers a promising target for new therapies.

Atherosclerosis otherwise known as hardening of the arteries is a prevalent cause of death in modern societies. The condition arises from the build-up of localized fatty deposits called plaques in the arteries. Macrophages, the phagocytic cells of the immune system, migrate to these sites, inducing chronic inflammation which exacerbates the accumulation of the atherosclerotic lesions. These can lead to obstruction of major vessels, causing heart attack and stroke. A team of medical researchers led by LMU's Professor Andreas Schober has now identified a microRNA (miRNA) that helps initiate the inflammatory process.

miRNAs are short segments of RNA derived from longer precursors transcribed from defined stretches of the genomic DNA. They act as versatile regulators of gene expression in cells, and also control the function of macrophages, in which patterns of gene activity must respond rapidly to changes in the extracellular environment. "However, the miRNAs that control the inflammation process during the various stages of atherosclerosis had not been identified up to now," says Schober.

In an earlier study, Schober and his team had shown that the microRNA miR-155 is a prominent member of the miRNA population in macrophages. The molecule prevents the synthesis of a protein that inhibits the inflammatory reaction, and thus promotes the progression of atherosclerosis. However, miR-155 does not serve as the initiator of inflammation. Schober and his colleagues have now looked at the patterns of microRNA expression in atherosclerotic lesions in the mouse, and noted that levels of a different miRNA, called miR-342-5p, increase in very early plaque
'/>"/>

Contact: Luise Dirscherl
dirscherl@lmu.de
49-892-180-2706
Ludwig-Maximilians-Universitt Mnchen
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Brain waves challenge area-specific view of brain activity
2. Researchers propose a novel prognostic model for disease-specific survival in BCa patients
3. Stroke risk in elderly treated with antipsychotics is newly linked to specific drug actions
4. US Drug Watchdog Now Urges Personal Injury Law Firms To Help Them Help Injured Individuals Of A Transvaginal Mesh Failure With A State Specific Approach-The Worst Victims
5. US Drug Watchdog Now Urges Top Personal Injury Trial Lawyers To Join Their State Specific Effort To Help Victims Of A Severe Transvaginal Mesh Failure To Get Compensation
6. US Drug Watchdog Now Invites Top Personal Injury Law Firms To Join Them In A State Specific Effort To Identify And Help Victims Of A Severe Transvaginal Mesh Failure
7. US Drug Watchdog Now Urges AV Rated Law Firms To Help Them Help More Victims Of A Severe Transvaginal Mesh Failure With A State Specific Approach
8. US Drug Watchdog Now Urges Trial Law Firms To Join Them In Their Effort To Help Severely Injured Victims Of A Transvaginal Mesh Failure-With A State Specific Approach
9. Prostate-specific antigen screening: Values and techniques shape decisions
10. Specific warning signs of complications in colorectal surgical patients released
11. US Drug Watchdog Now Urges All US Recipients of All Metal Hip Implants to Get a Blood Test For Cobalt-Chromium Levels and They Offer Specific Law Firms For Failure Victims
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... ... July 29, 2015 , ... Orthopedic surgeons at Lourdes ... the Rotation Medical Rotator Cuff System, a new implant to treat a common source ... to foster natural regeneration of additional tendon tissue, which could allow for faster healing ...
(Date:7/29/2015)... ... ... Today marks a significant achievement in bringing new monies into early stage companies. ... a group of experienced investors, has tapped into an investor community passionate about Sofia’s ... part of the fund. The Sofia Fund II is now closed to investors, ...
(Date:7/29/2015)... , ... July 29, 2015 , ... We are privileged to announce that U.S. ... USC as the ninth best ophthalmology hospital in the nation for 2015-2016. This marks the ... hospitals for ophthalmology. , “It is an honor to be included in the top ...
(Date:7/29/2015)... KY (PRWEB) , ... July 29, 2015 , ... ... episode of American Farmer, airing fall of 2015 on RFD-TV. , Fastline is ... viewers will learn about Fastline.com, which contains the largest and freshest searchable agriculture ...
(Date:7/29/2015)... , ... July 29, 2015 , ... ... the Hackett Hemwall Foundation in March, Steven W. Meier M.D., a prominent orthopedic ... treatments to qualifying patients with demonstrated financial need. , “We are thrilled for ...
Breaking Medicine News(10 mins):Health News:Lourdes Orthopedics First in NJ to Offer Bioinductive Implant for Rotator Cuff Repair 2Health News:Lourdes Orthopedics First in NJ to Offer Bioinductive Implant for Rotator Cuff Repair 3Health News:Sofia Fund Surpasses Investor Goals 2Health News:21 Years & Counting: The USC Eye Institute Ranks in the Top 10 Ophthalmology Hospitals in America 2Health News:21 Years & Counting: The USC Eye Institute Ranks in the Top 10 Ophthalmology Hospitals in America 3Health News:Fastline Publications to Partner with American Farmer in Upcoming Episode Airing on RFD-TV 2Health News:Orthopedic Surgeon Announces New Pro Bono Prolotherapy and Regenerative Medicine Clinic for Underserved Communities in Los Angeles 2
... 11 HLTH Corporation,(Nasdaq: HLTH ) today announced ... cash, of its 48% minority interest in Emdeon Business ... General Atlantic,previously acquired a 52% majority interest in Emdeon ... Wygod, Chairman and Acting CEO of HLTH, said: "HLTH ...
... Washington, DC When the public considers competing arguments about ... to agree with the expert whose values are closest to ... same will hold true for nanotechnology, a key study has ... issued today by the Project on Emerging Nanotechnologies (PEN). The ...
... Md., Feb. 11 "Psoriasis Cure,Now," a nonprofit ... Institutes of Health (NIH) for delivering a record ... 2007. Psoriasis research has,traditionally been underfunded at NIH. ... 159% (before inflation), but psoriasis and psoriatic,arthritis research ...
... recent years, increasing attention,has been paid to the ... In some instances, proponents of LBA made,overly-optimistic claims ... predictor in,the underwriting process. Milliman expert Jonathan Shreve, ... effective use of Lifestyle-Based,Analytics as an advance in ...
... (Amex: PTN ) announced today financial results for ... net loss of $3.8 million, or,($0.04) per basic and ... to a net loss of $6.5 million, or ($0.09) ... 2006. Total revenues for the quarter,ended December 31, 2007 ...
... to Ten Properties in New Jersey and Eighteen ... Brandywine Senior Living, a,premier owner and operator of ... the acquisition of a four-property portfolio from,Meridian Health ... New,Jersey, the portfolio has more than 380 suites. ...
Cached Medicine News:Health News:HLTH Corporation Sells its Minority Interest in Emdeon Business Services to General Atlantic and Hellman & Friedman for $575 Million 2Health News:HLTH Corporation Sells its Minority Interest in Emdeon Business Services to General Atlantic and Hellman & Friedman for $575 Million 3Health News:Nanotechnology's future depends on who the public trusts 2Health News:Psoriasis Cure Now Applauds Record Government Psoriasis Research Funding 2Health News:Milliman Expert Addresses Practical Applications of Lifestyle-Based Analytics in Risk Selection 2Health News:Palatin Technologies, Inc. Reports Fiscal Year 2008 Second Quarter Results; Teleconference and Webcast to be held on February 11, 2008 2Health News:Palatin Technologies, Inc. Reports Fiscal Year 2008 Second Quarter Results; Teleconference and Webcast to be held on February 11, 2008 3Health News:Palatin Technologies, Inc. Reports Fiscal Year 2008 Second Quarter Results; Teleconference and Webcast to be held on February 11, 2008 4Health News:Palatin Technologies, Inc. Reports Fiscal Year 2008 Second Quarter Results; Teleconference and Webcast to be held on February 11, 2008 5Health News:Palatin Technologies, Inc. Reports Fiscal Year 2008 Second Quarter Results; Teleconference and Webcast to be held on February 11, 2008 6Health News:Brandywine Senior Living Completes Acquisition of Four Assisted Living Communities in New Jersey 2
(Date:7/29/2015)... The Judicial Panel on Multidistrict Litigation (JPML) ... centralize Inferior vena cava (IVC) Filter lawsuits filed against ... have already been centralized by the JPML. ... risk for a pulmonary embolism. The filters are designed ... Claims against Bard and Cook involve incidents of retrievable ...
(Date:7/29/2015)... -- Research and Markets( http://www.researchandmarkets.com/research/h85dj3/pharmaceutical ) ... Market by Packaging Type, by Raw Material, by Drug ... Forecasts to 2020" report to their offering. ... is estimated to reach above $80 Billion by 2020 ... show a steady growth rate in the coming years. ...
(Date:7/29/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/hmjqff/global_wound_care ) has ... Care Markets (Twelve Country Analysis: Germany, France, Italy, ... Brazil, Australia, South Korea)" report to their ... competitive market summary. The wound care market is ... product maturity. Several of the products within the ...
Breaking Medicine Technology:IVC filter litigation continues; law firm provides free information to IVC filter patients 2Pharmaceutical Packaging Market by Packaging Type, Raw Material & Drug Delivery Type - Forecasts to 2020 for the $80 Billion Industry 2Pharmaceutical Packaging Market by Packaging Type, Raw Material & Drug Delivery Type - Forecasts to 2020 for the $80 Billion Industry 3Global Wound Care Markets 2015 2
... Blood fluoride levels were significantly higher in patients with ... in Biological Trace Element Research (April 2009). ... children and young adults.Randhu and colleagues measured serum fluoride ... patients. Group one had osteosarcoma, group two had non-osteosarcoma ...
... 29 Stallergenes S.A.,announces the release of the first ... on a sublingual house dust mite desensitization tablet. , ... the outcome of this study, which is the first,large ... mites allergen in,treating perennial allergic rhinitis. Furthermore, the unexpected ...
Cached Medicine Technology:Another Study Links Fluoride to Bone Cancer 2Stallergenes S.A.: Positive Results From a Phase IIb/III Clinical Trial on the House Dust Mite Desensitization Tablet 2Stallergenes S.A.: Positive Results From a Phase IIb/III Clinical Trial on the House Dust Mite Desensitization Tablet 3Stallergenes S.A.: Positive Results From a Phase IIb/III Clinical Trial on the House Dust Mite Desensitization Tablet 4
HME only...
Indications For Usage: ,Adult (recommended tidal volume >150ml), single patient use on anesthetized patients and respiratory care patients who require a breathing circuit. The product is intended to ...
Indications For Usage: ,Adult (recommended tidal volume >150ml), single patient use on anesthetized patients and respiratory care patients who require a breathing circuit. The product is intended to...
... T helps provide protection to the exposed airway ... extremely lightweight making it ideal for active young ... rate of heat and moisture recovery, it ensures ... HMEs and filters have ISO standard tapered ends ...
Medicine Products: